#abbvie — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #abbvie, aggregated by home.social.
-
AbbVie Announces European Commission Approval of RINVOQ® for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
RINVOQ is the first and only systemic medication approved in the European Union to treat adult and adolescent…
#Europe #EU #ABBV #AbbVie #EuropeanUnion #nyse-abbv #pharmaceutical-investing
https://www.europesays.com/europe/104804/ -
🔹Welt-Hepatitis-Tag: Kostenlose Hepatitis-C-Testaktion im Kontaktladen der Drogenberatung🔹
Anlässlich des Welt-Hepatitis-Tags am gestrigen Dienstag, 28. Juli, fand im Kontaktladen der Abteilung Drogenberatung und Prävention der Stadt Ludwigshafen, eine kostenlose Testaktion auf Hepatitis-C-Viren statt. Unterstützt wurde die Aktion durch das Biopharmaunternehmen #AbbVie. -
🔹Welt-Hepatitis-Tag: Kostenlose Hepatitis-C-Testaktion im Kontaktladen der Drogenberatung🔹
Anlässlich des Welt-Hepatitis-Tags am gestrigen Dienstag, 28. Juli, fand im Kontaktladen der Abteilung Drogenberatung und Prävention der Stadt Ludwigshafen, eine kostenlose Testaktion auf Hepatitis-C-Viren statt. Unterstützt wurde die Aktion durch das Biopharmaunternehmen #AbbVie. -
🔹Welt-Hepatitis-Tag: Kostenlose Hepatitis-C-Testaktion im Kontaktladen der Drogenberatung🔹
Anlässlich des Welt-Hepatitis-Tags am gestrigen Dienstag, 28. Juli, fand im Kontaktladen der Abteilung Drogenberatung und Prävention der Stadt Ludwigshafen, eine kostenlose Testaktion auf Hepatitis-C-Viren statt. Unterstützt wurde die Aktion durch das Biopharmaunternehmen #AbbVie. -
🔹Welt-Hepatitis-Tag: Kostenlose Hepatitis-C-Testaktion im Kontaktladen der Drogenberatung🔹
Anlässlich des Welt-Hepatitis-Tags am gestrigen Dienstag, 28. Juli, fand im Kontaktladen der Abteilung Drogenberatung und Prävention der Stadt Ludwigshafen, eine kostenlose Testaktion auf Hepatitis-C-Viren statt. Unterstützt wurde die Aktion durch das Biopharmaunternehmen #AbbVie. -
AbbVie Gets EU Approval for RINVOQ in Vitiligo
RINVOQ is the first and only systemic medication approved in the European Union to treat adult and adolescent…
#Europe #EU #EuropeanCommission #ABBV #AbbVie #EuropeanCommissionapproval #non-segmentalvitiligo #Phase3Viti-Up #repigmentation #RINVOQ #upadacitinib
https://www.europesays.com/europe/104745/ -
AbbVie RINVOQ Gets EU Approval for Severe Alopecia
RINVOQ® is now approved in the European Union for the treatment of adult and adolescent patients with severe…
#Europe #EU #EuropeanCommission #ABBV #AbbVie #alopeciaareata #EuropeanCommissionapproval #JAKinhibitor #Phase3UP-AA #RINVOQ #scalphairregrowth
https://www.europesays.com/europe/104737/ -
How Investors May Respond To AbbVie (ABBV) Securing EU Approval For Short-Acting Boey Aesthetic Toxin
In July 2026, Allergan Aesthetics, an AbbVie company, received European Commission approval for Boey (trenibotulinumtoxinE), a rapid-onset, short-duration…
#Europe #EU #AbbVie #Boey #EuropeanUnion #facialaesthetics
https://www.europesays.com/europe/99538/ -
https://www.europesays.com/uk/1095559/ AbbVie (ABBV) Wins EU Approval For Boey Frown Line Treatment In Europe #AbbVie #AllerganAesthetics #boey #EU #Europe #European #EuropeanAesthetics #SimplyWallSt #TreatmentDuration
-
AbbVie (ABBV) Wins EU Approval For Boey Frown Line Treatment In Europe
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
#Europe #EU #AbbVie #AllerganAesthetics #Boey #Europeanaesthetics #EuropeanUnion #SimplyWallSt #treatmentduration
https://www.europesays.com/europe/96977/ -
Allergan Aesthetics receives approval for Boey® , for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients
Boey® is the first and only rapid-onset and short-duration botulinum neurotoxin serotype E approved in Europe that adult…
#Europe #EU #ABBV #AbbVie #nyse-abbv #pharmaceutical-investing
https://www.europesays.com/europe/96688/ -
Allergan Aesthetics receives approval for Boey® , for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients https://www.byteseu.com/2203741/ #abbv #AbbVie #Europe #NyseAbbv #PharmaceuticalInvesting
-
Why US multinationals keep choosing Ireland. It’s not just the tax or workforce – The Irish Times
If you ask US multinationals why they choose Ireland as a base for investment, they’ll talk about the…
#NewsBeep #News #Economy #AbbVie #Alphabet #Apple #Business #feargal-orourke #GileadSciences #ida-ireland #merck #Microsoft #stryker #UK #UnitedKingdom
https://www.newsbeep.com/uk/684198/ -
https://www.europesays.com/ie/578158/ Why US multinationals keep choosing Ireland. It’s not just the tax or workforce – The Irish Times #AbbVie #Alphabet #Apple #Business #Economy #Éire #FeargalOrourke #GileadSciences #IDAIreland #IE #Ireland #Merck #Microsoft #Stryker
-
https://www.europesays.com/es/649987/ Actualidad para la innovación farmacéutica #abbvie #AstraZeneca #Business #D1 #DaiichiSankyo #Economía #Economy #ES #España #johnson&johnson #Laboratorios #roche #Spain
-
EU Approves Expanded Use of ABBV’s Tepkinly in Follicular Lymphoma
AbbVie ABBV announced that the European Commission (EC) approved the expanded use of Tepkinly (epcoritamab) for the relapsed or…
#Europe #EU #ABBV #AbbVie #adultpatients #AmarinCorporation #EuropeanCommission #EuropeanUnion #follicularlymphoma #R/RFL #systemictherapy #ZacksInvestmentResearch
https://www.europesays.com/europe/88824/ -
AbbVie Announces TEPKINLY® in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma
TEPKINLY® (epcoritamab) plus lenalidomide and rituximab (R2) is the first and only bispecific-based therapy approved in Europe for…
#Europe #EU #EuropeanCommission #ABBV #AbbVie #nyse-abbv #pharmaceutical-investing
https://www.europesays.com/europe/87767/ -
AbbVie TEPKINLY approved in EU for follicular lymphoma
TEPKINLY® (epcoritamab) plus lenalidomide and rituximab (R2) is the first and only bispecific-based therapy approved in Europe for…
#Europe #EU #EuropeanCommission #ABBV #AbbVie #epcoritamab #follicularlymphoma #marketingauthorization #oncology #TEPKINLY
https://www.europesays.com/europe/87729/ -
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or…
#NewsBeep #News #Medication #AbbVie #chronicconditions #Health #Healthcareprovider #NationalPsoriasisFoundation #pediatricpatients #plaquepsoriasis #PsoriaticArthritis #sideeffects #SKYRIZI #treatment #UK #UnitedKingdom
https://www.newsbeep.com/uk/661387/ -
https://www.europesays.com/ie/557155/ SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease #AbbVie #ChronicConditions #Éire #Health #HealthcareProvider #IE #Ireland #Medication #NationalPsoriasisFoundation #PediatricPatients #PlaquePsoriasis #PsoriaticArthritis #SideEffects #SKYRIZI #treatment
-
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #AbbVie #chronicconditions #Health #Healthcareprovider #NationalPsoriasisFoundation #pediatricpatients #plaquepsoriasis #PsoriaticArthritis #sideeffects #SKYRIZI #Treatment
https://www.newsbeep.com/us/729138/ -
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #AbbVie #chronicconditions #Health #Healthcareprovider #NationalPsoriasisFoundation #pediatricpatients #plaquepsoriasis #PsoriaticArthritis #sideeffects #SKYRIZI #Treatment
https://www.newsbeep.com/us/729138/ -
https://www.europesays.com/uk/1053419/ SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease #AbbVie #ChronicConditions #Health #HealthcareProvider #Medication #NationalPsoriasisFoundation #PediatricPatients #PlaquePsoriasis #PsoriaticArthritis #SideEffects #SKYRIZI #treatment #UK #UnitedKingdom
-
64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital
Quick Read KO and ABBV anchor the portfolio at 25% each, rated Very Safe with payout ratios under…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Personalfinance #ABBV #AbbVie #Business #dividendyields #freecashflow #ModerateRisk #PersonalFinance #top10AIstocks #traditionalIRA #Verizon
https://www.newsbeep.com/us/724545/ -
64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital
Quick Read KO and ABBV anchor the portfolio at 25% each, rated Very Safe with payout ratios under…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Personalfinance #ABBV #AbbVie #Business #dividendyields #freecashflow #ModerateRisk #PersonalFinance #top10AIstocks #traditionalIRA #Verizon
https://www.newsbeep.com/us/724545/ -
64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital
Quick Read KO and ABBV anchor the portfolio at 25% each, rated Very Safe with payout ratios under…
#NewsBeep #News #Personalfinance #ABBV #AbbVie #AU #Australia #Business #dividendyields #Finance #freecashflow #ModerateRisk #PersonalFinance #top10AIstocks #traditionalIRA #Verizon
https://www.newsbeep.com/au/758541/ -
64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital
Quick Read KO and ABBV anchor the portfolio at 25% each, rated Very Safe with payout ratios under…
#NewsBeep #News #Personalfinance #ABBV #AbbVie #AU #Australia #Business #dividendyields #Finance #freecashflow #ModerateRisk #PersonalFinance #top10AIstocks #traditionalIRA #Verizon
https://www.newsbeep.com/au/758541/ -
https://www.europesays.com/ie/552739/ 64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital #ABBV #AbbVie #Business #DividendYields #Éire #FreeCashFlow #IE #Ireland #ModerateRisk #PersonalFinance #PersonalFinance #Top10AIStocks #TraditionalIRA #Verizon
-
AbbVie Gets EU Nod for Skyrizi in Pediatric Plaque Psoriasis
AbbVie ABBV announced that the European Commission (EC) has approved its blockbuster immunology drug, Skyrizi (risankizumab), for treating children…
#Europe #EU #AbbVie #approvedindications #chronicHCVinfection #EuropeanCommission #EuropeanUnion #HCVinfection #operationalbasis #plaquepsoriasis #SKYRIZI #ZacksInvestmentResearch
https://www.europesays.com/europe/78381/ -
AbbVie Announces European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus Infection
MAVIRET® (glecaprevir/pibrentasvir) is now approved in the European Union for the treatment of acute hepatitis C virus (HCV)…
#Europe #EU #EuropeanCommission #AbbVie #antiviral #chronicHCVinfection #HCVinfection #hepatitisC #MAVIRET #TheEuropeanUnion
https://www.europesays.com/europe/77996/ -
AbbVie wins EU approval for SKYRIZI in children
SKYRIZI® (risankizumab) expands its indication for children and adolescents six years of age and older with moderate to…
#Europe #EU #EuropeanCommission #ABBV #AbbVie #biopharma #EuropeanCommissionapproval #pediatricplaquepsoriasis #Phase3 #risankizumab #SKYRIZI
https://www.europesays.com/europe/77471/ -
AbbVie Announces European Commission Approval of MAVIRET® for People with Acute Hepatitis C Virus Infection
MAVIRET® (glecaprevir/pibrentasvir) is now approved in the European Union for the treatment of acute hepatitis C virus (HCV)…
#Europe #EU #ABBV #AbbVie #European #nyse-abbv #pharmaceutical-investing
https://www.europesays.com/europe/77019/ -
https://www.europesays.com/news/43886/ US stocks drift after oil prices ease and Big Tech stocks fall #AbbVie #AmazonCom #ApogeeTherapeutics #BroadcomInc #Business #CMEGroup #EnergyMarkets #FederalReserveSystem #FinanceBusiness #FinancialMarkets #FinancialBusiness #GeneralNews #Headlines #Inc #Iran #IranWar #KeirStarmer #News #OilAndGasIndustry #SpaceX #StocksAndBonds #TopStories #WorldNews
-
https://www.europesays.com/iran/172547/ US stocks drift near their records after oil prices fall #AbbVie #ApogeeTherapeutics #Business #CMEGroup #EnergyMarkets #FederalReserveSystem #FinancialMarkets #GeneralNews #Inc #Iran #IranWar #KeirStarmer #OilAndGasIndustry #SpaceX #StocksAndBonds #WorldNews
-
US stocks drift near their records after oil prices fall
NEW YORK (AP) — U.S. stocks are drifting near their records in mixed trading Monday after trading resumed…
#NewsBeep #News #BreakingNews #AbbVie #ApogeeTherapeutics #breakingnews #Business #CMEGroup #energymarkets #FederalReserveSystem #financialmarkets #Generalnews #Inc. #Iran #iranwar #KeirStarmer #Oilandgasindustry #SpaceX #Stocksandbonds #Worldnews
https://www.newsbeep.com/605493/ -
US stocks drift near their records after oil prices fall
NEW YORK (AP) — U.S. stocks are drifting near their records in mixed trading Monday after trading resumed…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Business #AbbVie #ApogeeTherapeutics #CMEGroup #energymarkets #FederalReserveSystem #Financialmarkets #Generalnews #Inc. #iran #Iranwar #KeirStarmer #oilandgasindustry #spaceX #Stocksandbonds #Worldnews
https://www.newsbeep.com/us/719474/ -
US stocks drift near their records after oil prices fall
NEW YORK (AP) — U.S. stocks are drifting near their records in mixed trading Monday after trading resumed…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Business #AbbVie #ApogeeTherapeutics #CMEGroup #energymarkets #FederalReserveSystem #Financialmarkets #Generalnews #Inc. #iran #Iranwar #KeirStarmer #oilandgasindustry #spaceX #Stocksandbonds #Worldnews
https://www.newsbeep.com/us/719474/ -
US stocks drift near their records after oil prices fall
NEW YORK (AP) — U.S. stocks are drifting near their records in mixed trading Monday after trading resumed…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Business #AbbVie #ApogeeTherapeutics #CMEGroup #energymarkets #FederalReserveSystem #Financialmarkets #Generalnews #Inc. #iran #Iranwar #KeirStarmer #oilandgasindustry #spaceX #Stocksandbonds #Worldnews
https://www.newsbeep.com/us/719474/ -
3 Ridiculously Cheap Healthcare Stocks to Buy in June
Quick Read NVO sits 44% below its 52-week high with a price-to-free-cash-flow of 5 and a free cash…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #AbbVie #freecashflow #Health #HealthCareSelectSectorSPDRFund #NovoNordisk #nyse #operatingcashflow #top10AIstocks
https://www.newsbeep.com/us/702361/ -
3 Ridiculously Cheap Healthcare Stocks to Buy in June
Quick Read NVO sits 44% below its 52-week high with a price-to-free-cash-flow of 5 and a free cash…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #AbbVie #freecashflow #Health #HealthCareSelectSectorSPDRFund #NovoNordisk #nyse #operatingcashflow #top10AIstocks
https://www.newsbeep.com/us/702361/ -
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Investors seeking reliable dividends and healthcare exposure often find themselves choosing between AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE). Both…
#NewsBeep #News #Healthcare #AbbVie #AU #Australia #currentratio #Health #Pfizer #shareholderequity
https://www.newsbeep.com/au/709601/ -
Analysis: Market Outlook for AbbVie Following Recent Earnings Performance
📰 Original title: Watch: Why Investors Are Still Worried About AbbVie
🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️ -
Analysis: Market Outlook for AbbVie Following Recent Earnings Performance
📰 Original title: Watch: Why Investors Are Still Worried About AbbVie
🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️ -
Analysis: Market Outlook for AbbVie Following Recent Earnings Performance
📰 Original title: Watch: Why Investors Are Still Worried About AbbVie
🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️ -
Condamné à 850 000 €, le labo Abbvie paie (enfin) pour sa gestion opaque d’une pénurie critique. #medicament #AbbVie
https://www.lesmotsontunsens.com/penurie-de-medicaments-un-laboratoire-enfin-condamne/ -
Humira’s TrumpRx Discount Raises New Questions For AbbVie Valuation
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
#NewsBeep #News #Medication #AbbVie #AU #Australia #Health #Humira #individualinvestors #pricingdecision #whitehouse
https://www.newsbeep.com/au/594937/ -
Best Healthcare Stocks to Buy After the Market Pullback
Equity markets have moved in the wrong direction over the past three weeks. They may not rebound and…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #AbbVie #CVSHealth #geopoliticalissues #Health
https://www.newsbeep.com/us/535135/ -
If You Have $500,000 Saved at 60, Here’s The Sort of Monthly Income You Can Count On
Verizon (VZ) yields 5.4% at its current price, paying $0.69 per quarter and offering higher current income for…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Personalfinance #000 #500 #AbbVie #Business #dividendgrowth #lifetimeincome #monthlyincome #NVIDIA #PersonalFinance #retirementincome #socialsecurity #top10AIstocks
https://www.newsbeep.com/us/521524/ -
If You Have $500,000 Saved at 60, Here’s The Sort of Monthly Income You Can Count On
Verizon (VZ) yields 5.4% at its current price, paying $0.69 per quarter and offering higher current income for…
#NewsBeep #News #Personalfinance #000 #500 #AbbVie #AU #Australia #Business #dividendgrowth #Finance #lifetimeincome #monthlyincome #Nvidia #PersonalFinance #retirementincome #SocialSecurity #top10AIstocks
https://www.newsbeep.com/au/538198/ -
#Paris #Agriculture Fair moo-ves forward without the
https://kensbookinfo.blogspot.com/p/world-capitals.html#Paris#Trump’s moral flexibility on #Iran isn’t an asset —
https://kensbookinfo.blogspot.com/p/politics.html#14#Trump's new tariff comes into effect at lower than
https://kensbookinfo.blogspot.com/p/canada.html#14#AbbVie Invests $380M to Expand #Illinois #Manufacturing
https://kensbookinfo.blogspot.com/p/business.html#55#Kuwait dressed in national colors as citizens celebrate
https://kensbookinfo.blogspot.com/p/world-capitals.html#KuwaitCity#Europe’s War on Digital Speech
https://kensbookinfo.blogspot.com/p/politics.html#29 -
#Paris #Agriculture Fair moo-ves forward without the
https://kensbookinfo.blogspot.com/p/world-capitals.html#Paris#Trump’s moral flexibility on #Iran isn’t an asset —
https://kensbookinfo.blogspot.com/p/politics.html#14#Trump's new tariff comes into effect at lower than
https://kensbookinfo.blogspot.com/p/canada.html#14#AbbVie Invests $380M to Expand #Illinois #Manufacturing
https://kensbookinfo.blogspot.com/p/business.html#55#Kuwait dressed in national colors as citizens celebrate
https://kensbookinfo.blogspot.com/p/world-capitals.html#KuwaitCity#Europe’s War on Digital Speech
https://kensbookinfo.blogspot.com/p/politics.html#29 -
#Newteam takes on famous Lomax building where Oasis
https://kensbookinfo.blogspot.com/p/uk.html#lpool_echo#Paris #Agriculture Fair moo-ves forward without the
https://kensbookinfo.blogspot.com/p/world-capitals.html#Paris#Trump’s moral flexibility on #Iran isn’t an asset —
https://kensbookinfo.blogspot.com/p/politics.html#14#Trump's new tariff comes into effect at lower than
https://kensbookinfo.blogspot.com/p/canada.html#14#AbbVie Invests $380M to Expand #Illinois #Manufacturing
https://kensbookinfo.blogspot.com/p/business.html#55#Kuwait dressed in national colors as citizens celebrate
https://kensbookinfo.blogspot.com/p/world-capitals.html#KuwaitCity -
¿Por qué AbbVie prevé ganancias récord en 2026 gracias a la inmunología? La farmacéutica supera las expectativas y anticipa un crecimiento sostenido impulsado por nuevos medicamentos https://sagaroja.com/es/blog/empresas/abbvie-ganancias-inmunologia-2026 #Abbvie #Farmacuticas #Inmunologa
-
My Top 3 Healthcare Stocks to Buy in 2026
With its diverse product line, AbbVie is a terrific dividend stock with a solid underlying business. Eli Lilly…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #AbbVie #EliLilly #growthprospects #Health #IntuitiveSurgical #therapeuticareas
https://www.newsbeep.com/us/349477/ -
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026
One of these pharmaceutical leaders overcame a major obstacle and has a strong outlook. The other is actively…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #AbbVie #company #Health #Merck
https://www.newsbeep.com/us/345598/ -
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.
Skyrizi and Rinvoq sales are pushing AbbVie’s sales higher. UnitedHealth Group raised its full-year guidance and is rebounding…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #AbbVie #AbbViestock #DividendStocks #Health #Healthcarestocks #PharmaceuticalCompany #stockmarket #UnitedHealthGroup
https://www.newsbeep.com/us/282000/ -
ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression
AbbVie ABBV has announced a deal with private neuroscience biotech, Gilgamesh Pharmaceuticals, to acquire the latter’s lead pipeline…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #ABBV #AbbVie #GilgameshPharmaceuticals #Health #MADRS #MentalHealth #ZacksInvestmentResearch
https://www.newsbeep.com/us/115696/ -
Bloomberg: #Alphabet #shares rally 6% in early trading as the company's strength in #search #advertising helped profit beat estimates. #AbbVie, #Colgate-Palmolive and #Schlumberger are slated to report later. #Stocks and the dollar edge higher. #markets
-
Bloomberg: #Alphabet #shares rally 6% in early trading as the company's strength in #search #advertising helped profit beat estimates. #AbbVie, #Colgate-Palmolive and #Schlumberger are slated to report later. #Stocks and the dollar edge higher. #markets
-
Despite layoff announcements, Novartis beats Q2 expectations — GoodRx teams with Boehringer on Humira biosimilar— Medtech firms have cut more than 14,000 jobs in the past 18 months —http://bit.ly/w28kSd #novartis #earnings #layoffs #humira #biosimilar #goodrx #abbvie #medtech #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma